New COPD inhaler shows promise in Real-World study

NCT ID NCT06368427

Completed Symptom relief Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times

Summary

This study followed 10 adults with moderate to severe COPD in Romania who were starting a new inhaler called TRIXEO AEROSPHERE. Researchers wanted to see how patients felt about their health and treatment over 3 to 6 months. The goal was to understand real-world benefits, not to test if the drug works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Baia Mare, Romania
Research Site

Bucharest, Romania
Research Site

Cluj-Napoca, Romania
Research Site

Constanța, Romania
Research Site

Craiova, Romania
Research Site

Deva, Romania
Research Site

Dorohoi, Romania
Research Site

Hunedoara, Romania
Research Site

Iași, Romania
Research Site

Luduş, Romania
Research Site

Medgidia, Romania
Research Site

Oradea, Romania
Research Site

Sighișoara, Romania
Research Site

Suceava, Romania
Research Site

Târgu Mureş, Romania
Research Site

Timișoara, Romania

Conditions

Explore the condition pages connected to this study.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)